{
    "id": 19977,
    "fullName": "SMAD4 inact mut",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "SMAD4 inact mut indicates that this variant results in a loss of function of the Smad4 protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 4089,
        "geneSymbol": "SMAD4",
        "terms": [
            "SMAD4",
            "DPC4",
            "JIP",
            "MADH4",
            "MYHRS"
        ]
    },
    "variant": "inact mut",
    "createDate": "03/21/2016",
    "updateDate": "08/27/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5253,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, pancreatic cancer cell lines harboring inactivated SMAD4 (mutations or deletion) displayed 4.5-fold greater sensitivity to irinotecan in vitro than wild-type (PMID: 22753594).",
            "molecularProfile": {
                "id": 20414,
                "profileName": "SMAD4 inact mut"
            },
            "therapy": {
                "id": 1074,
                "therapyName": "Irinotecan",
                "synonyms": null
            },
            "indication": {
                "id": 1793,
                "name": "pancreatic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 917,
                    "pubMedId": 22753594,
                    "title": "Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22753594"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20414,
            "profileName": "SMAD4 inact mut",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}